» Articles » PMID: 33654105

Meta-analysis of Neural Systems Underlying Placebo Analgesia from Individual Participant FMRI Data

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Mar 3
PMID 33654105
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The brain systems underlying placebo analgesia are insufficiently understood. Here we performed a systematic, participant-level meta-analysis of experimental functional neuroimaging studies of evoked pain under stimulus-intensity-matched placebo and control conditions, encompassing 603 healthy participants from 20 (out of 28 eligible) studies. We find that placebo vs. control treatments induce small, widespread reductions in pain-related activity, particularly in regions belonging to ventral attention (including mid-insula) and somatomotor networks (including posterior insula). Behavioral placebo analgesia correlates with reduced pain-related activity in these networks and the thalamus, habenula, mid-cingulate, and supplementary motor area. Placebo-associated activity increases occur mainly in frontoparietal regions, with high between-study heterogeneity. We conclude that placebo treatments affect pain-related activity in multiple brain areas, which may reflect changes in nociception and/or other affective and decision-making processes surrounding pain. Between-study heterogeneity suggests that placebo analgesia is a multi-faceted phenomenon involving multiple cerebral mechanisms that differ across studies.

Citing Articles

"The Dark Side of Musculoskeletal Care": Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies.

Mamud-Meroni L, Tarcaya G, Carrasco-Uribarren A, Rossettini G, Flores-Cortes M, Ceballos-Laita L Biomedicines. 2025; 13(2).

PMID: 40002804 PMC: 11853516. DOI: 10.3390/biomedicines13020392.


The Two Sides of Placebo Analgesia: Differential Functional Connectivity Reveals Mechanisms of Placebo Analgesic Response.

Bush N, Cushnie A, Boissoneault J, Aghabeigi S, Alexander C, Staud R J Pain Res. 2025; 18():189-201.

PMID: 39816204 PMC: 11733195. DOI: 10.2147/JPR.S483157.


Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia.

Neyama H, Wu Y, Nakaya Y, Kato S, Shimizu T, Tahara T Sci Adv. 2025; 11(3):eadp8494.

PMID: 39813331 PMC: 11734720. DOI: 10.1126/sciadv.adp8494.


Explainable fNIRS-based pain decoding under pharmacological conditions via deep transfer learning approach.

Eken A, Yuce M, Yukselen G, Erdogan S Neurophotonics. 2024; 11(4):045015.

PMID: 39691581 PMC: 11651663. DOI: 10.1117/1.NPh.11.4.045015.


Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain.

Coxon L, Amer M, Daniels J, Doust A, Mackenzie S, Horne A Front Pharmacol. 2024; 15:1460206.

PMID: 39691398 PMC: 11649436. DOI: 10.3389/fphar.2024.1460206.


References
1.
Soon C, Brass M, Heinze H, Haynes J . Unconscious determinants of free decisions in the human brain. Nat Neurosci. 2008; 11(5):543-5. DOI: 10.1038/nn.2112. View

2.
Brett M, Johnsrude I, Owen A . The problem of functional localization in the human brain. Nat Rev Neurosci. 2002; 3(3):243-9. DOI: 10.1038/nrn756. View

3.
Wager T, Rilling J, Smith E, Sokolik A, Casey K, Davidson R . Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004; 303(5661):1162-7. DOI: 10.1126/science.1093065. View

4.
Wager T, Scott D, Zubieta J . Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007; 104(26):11056-61. PMC: 1894566. DOI: 10.1073/pnas.0702413104. View

5.
Zunhammer M, Bingel U, Wager T . Placebo Effects on the Neurologic Pain Signature: A Meta-analysis of Individual Participant Functional Magnetic Resonance Imaging Data. JAMA Neurol. 2018; 75(11):1321-1330. PMC: 6248115. DOI: 10.1001/jamaneurol.2018.2017. View